Results 141 to 150 of about 175,691 (288)

Operationalizing BioSSbD: A safe‐and‐sustainable‐by‐design framework for biorefineries

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Biorefineries are central to the transition toward a circular bioeconomy; however, their increasing scale and technological heterogeneity, and the integration of biological, chemical, and thermochemical processes introduce complex challenges related to safety, sustainability, and operational reliability. Existing Safe‐and‐Sustainable‐by‐Design
Fernando Ramonet
wiley   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Evaluating future powertrain and recycling technologies and their impact on the life cycle assessment and costing of mid-size and large passenger vehicles

npj Sustainable Mobility and Transport
Electrification is needed to improve the environmental performance of the transportation sector but must be accompanied by technological innovations that eliminate ecological hotspots over the vehicle’s lifetime.
Milad Golkaram, Tom Ligthart, Aylin Yildiran, Rajesh Mehta, Jack J. T. W. E. Vogels, Spela Ferjan, Eugene Someren   +6 more
doaj   +1 more source

Institutional Challenges in the Data Decade

, 2011
Throughout the year, the DCC stages regional data management roadshows to present best practice and showcase new tools and resources. This article reports on the second roadshow, organised in conjunction with the White Rose University Consortium and held
Tattersall, Marion, O'Dell, Carmen, Lewis, John   +2 more
core  

Through the lens of marketing authorization holders: experience in use of real‐world data and real‐world evidence in drug development and regulatory submissions in EU

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola, Aleksandar Gigov, Hubertus G. M. Leufkens, Andrew Bate, Marie Louise De Bruin, Helga Gardarsdottir   +5 more
wiley   +1 more source

Active surveillance of drug safety in healthcare data: Sequential monitoring of bacterial and serious urinary tract infection risk in sodium‐glucose cotransporter 2 inhibitor users

British Journal of Clinical Pharmacology, EarlyView.
Abstract Introduction Active surveillance of adverse events using healthcare data is emerging as complementary to the monitoring of spontaneous reports and stand‐alone pharmacoepidemiologic studies. The risk of urinary tract infections (UTIs) was listed as a special warning for sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) when marketed in Europe
Haoxin Le, Dilsad Simay Peker, Lukas Frederic Westphal, Nikolai Brun, Christine Erikstrup Hallgreen, Morten Andersen   +5 more
wiley   +1 more source

Educational Content - Lifecycle Courses

The educational content developed to offer a general orientation for investors with content specifically targeting new investors, women investors and minorities.
openaire   +1 more source

Enterprise content management solutions in the context of information lifecycle management (ILM).

, 2010
Enterprise Content Management is an interesting science. Software related to managing such content has proliferated over the years and recent acquisitions in the ECM industry show how widespread its adoption is and its strength in the information technology market.
openaire   +1 more source

Academic misconduct appeal services in China: Platform logics, self‐platformization and implications for integrity education

British Educational Research Journal, EarlyView.
Abstract Academic misconduct appeal services have quietly emerged within China's education marketplace, with commercial agencies promoting themselves on social media to assist international students facing misconduct hearings. While existing research on academic integrity has emphasized prevention and detection, far less attention has been paid to what
Gengyan Tang, Sarah Elaine Eaton, Wei Cai   +2 more
wiley   +1 more source